Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Vernalis plc    VER   GB00B3Y5L754

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
08/24/2015 08/25/2015 08/26/2015 08/27/2015 08/28/2015 Date
71(c) 75(c) 74(c) 75.25(c) 78.25(c) Last
950 781 263 268 91 509 33 389 192 021 Volume
-4.38% +5.63% -1.33% +1.69% +3.99% Change
More quotes
Financials ( GBP)
Sales 2015 18,5 M
EBIT 2015 -15,6 M
Net income 2015 -11,0 M
Finance 2015 34,3 M
Yield 2015 -
Sales 2016 -
EBIT 2016 -
Net income 2016 -
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016 -
Capi. / Sales 2015 16,1x
Capi. / Sales 2016 -
Capitalization 334 M
More Financials
Company
Vernalis Plc is a research and development stage pharmaceutical company.The company provides pharmaceutical products for a range of medical disorders.It focuses on de novo fragment and structure based drug discovery and pre clinical and clinical development.The group has one marketed product,... 
More about the company
Surperformance© ratings of Vernalis plc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERNALIS PLC
08/21 VERNALIS : completes investment in its NCE development pipeline
08/20 VERNALIS : Says Product Fails To Meet Pain Reduction Primary Endpoint
08/18 VERNALIS : Appointment of Non-Executive Director
08/18 VERNALIS : Appointment of Non-Executive Director
08/18 VERNALIS : Appointment of Non-Executive Director
08/17 VERNALIS : Appointment of Non-Executive Director
06/30 VERNALIS : Appointment of Non-Executive Director
06/30 VERNALIS : Appointment of Non-Executive Director
More news
Sector news : Biotechnology & Medical Research - NEC
08:01a QUINTILES TRANSNATIONAL : CEO to Present at UBS Best of Americas 2015 Conference
08/27 ACTELION : Additional data on selexipag (uptravi) and macitentan (opsumit) to be..
08/27 GENMAB A/S : Data Published in The New England Journal of Medicine Shows Daratum..
More sector news : Biotechnology & Medical Research - NEC


Comments 
Advertisement
Chart VERNALIS PLC
Duration : Period :
Vernalis plc Technical Analysis Chart | VER | GB00B3Y5L754 | 4-Traders
Full-screen chart
Technical analysis trends VERNALIS PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions